These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 2574424)

  • 1. Desenkephalin-gamma-endorphin is an antagonist of the hyperactivity response induced by infusion of dopamine into the nucleus accumbens of rat and ventral striatum of marmoset.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1989 Nov; 28(11):1223-9. PubMed ID: 2574424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the 5-HT3 receptor antagonist, GR38032F, on raised dopaminergic activity in the mesolimbic system of the rat and marmoset brain.
    Costall B; Domeney AM; Naylor RJ; Tyers MB
    Br J Pharmacol; 1987 Dec; 92(4):881-94. PubMed ID: 2962686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Behavioural consequences of the infusion of dopamine into the nucleus accumbens of the common marmoset (Callithrix jacchus).
    Barnes NJ; Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1987 Sep; 26(9):1327-35. PubMed ID: 2890118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketotifen can antagonise changes in sensitivity of cerebral dopamine receptors: behavioural correlates in rodent and primate.
    Barnes JC; Barnes NJ; Barnes NM; Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1987 Jul; 26(7A):693-700. PubMed ID: 3114665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term consequences of antagonism by neuroleptics of behavioural events occurring during mesolimbic dopamine infusion.
    Costall B; Domeney AM; Naylor RJ
    Neuropharmacology; 1984 Mar; 23(3):287-94. PubMed ID: 6145111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-opiate beta-endorphin fragments and dopamine--VI. Behavioural analysis of the interaction between gamma-type endorphins and dopaminergic systems in the nucleus accumbens of rats.
    Király I; Van Ree JM
    Neuropharmacology; 1984 May; 23(5):511-6. PubMed ID: 6204246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the behavioural consequences of chronic stimulation of dopamine receptors in the nucleus accumbens of rat brain effected by a continuous infusion or by single daily injections.
    Costall B; Domeney AM; Naylor RJ
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Sep; 324(1):27-33. PubMed ID: 6633677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The neuroleptic-like peptide desenkephalin-gamma-endorphin does not antagonize the dopamine receptor agonist-induced inhibition of the release of [3H]dopamine from rat nucleus accumbens slices in vitro.
    Radhakishun FS; Stoof JC; Mulder AH; Versteeg DH; van Ree JM
    Brain Res; 1987 Nov; 426(2):235-42. PubMed ID: 2961411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Locomotor hyperactivity caused by dopamine infusion into the nucleus accumbens of rat brain: specificity of action.
    Costall B; Domeney AM; Naylor RJ
    Psychopharmacology (Berl); 1984; 82(3):174-80. PubMed ID: 6144126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The actions of (-)N-n-propylnorapomorphine and selective dopamine D1 and D2 receptor agonists to modify the release of [3H]dopamine from the rat nucleus accumbens.
    Barnes JM; Barnes NM; Costall B; Naylor RJ
    Neuropharmacology; 1990 Apr; 29(4):327-36. PubMed ID: 1971430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subchronic treatment with the neuroleptic-like peptide desenkephalin-gamma-endorphin may decrease dopaminergic neurotransmission in the nucleus accumbens of rats.
    Radhakishun FS; Westerink BH; Stoof JC; Wolterink G; van Ree JM
    Eur Neuropsychopharmacol; 1994 Jun; 4(2):127-36. PubMed ID: 7919942
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine release in the nucleus accumbens of freely moving rats determined by on-line dialysis: effects of apomorphine and the neuroleptic-like peptide desenkephalin-gamma-endorphin.
    Radhakishun FS; Westerink BH; van Ree JM
    Neurosci Lett; 1988 Jul; 89(3):328-34. PubMed ID: 2901702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The hypomotility elicited by small doses of apomorphine seems exclusively mediated by dopaminergic systems in the nucleus accumbens.
    Radhakishun FS; Van Ree JM
    Eur J Pharmacol; 1987 May; 137(1):41-7. PubMed ID: 3609134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lithium and bupropion antagonise the phasic changes in locomotor activity caused by dopamine infused into the rat nucleus accumbens.
    Barnes JC; Costall B; Domeney AM; Naylor RJ
    Psychopharmacology (Berl); 1986; 89(3):311-6. PubMed ID: 3088656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotypies elicited by injection of N-propylnorapomorphine into striatal subregions and nucleus accumbens.
    Bordi F; Carr KD; Meller E
    Brain Res; 1989 Jun; 489(2):205-15. PubMed ID: 2568153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Locomotor activation induced by MK-801 in the rat: postsynaptic interactions with dopamine receptors in the ventral striatum.
    Ouagazzal A; Nieoullon A; Amalric M
    Eur J Pharmacol; 1994 Jan; 251(2-3):229-36. PubMed ID: 8149978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of dopamine function by glycine in the nucleus accumbens of the brain of the rat.
    Barnes JC; Costall B; Naylor RJ
    Neuropharmacology; 1986 Dec; 25(12):1347-51. PubMed ID: 3561713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of mesolimbic dopaminergic projections by beta-endorphin in the rat.
    Iyengar S; Kim HS; Marien MR; McHugh D; Wood PL
    Neuropharmacology; 1989 Feb; 28(2):123-8. PubMed ID: 2524013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Desenkephalin-gamma-endorphin and neuroleptics counteract the DP-7-ATN-induced hypomotility after intra-accumbens treatment.
    Radhakishun FS; Horn AS; Van Ree JM
    Eur J Pharmacol; 1988 Feb; 147(1):137-40. PubMed ID: 2897307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat.
    Ford AP; Marsden CA
    Brain Res; 1990 Nov; 534(1-2):243-50. PubMed ID: 2073584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.